The programme is run by an operator, chosen and contracted for this purpose by the company marketing the medicinal product.
The operator is chosen on the basis of the guarantees of independence that it offers, in particular those mentioned in 1° of article R. 1161-24, its skills and the human and material resources it has available to carry out the tasks involved in implementing the learning programme.
The agreement specifies that the company and the operator will only have access to anonymised patient data.